Intervet Inc., which recently received approval for its canine diabetes treatment Vetsulin, has formed a new Companion Animal Business Team to support its expansion in this market. "By having a focused team of professional sales, marketing and technical services representatives, Intervet is underscoring the importance of better serving U.S. companion animal veterinarians," said Dr. Sebastien Huron, director of the new team. "Intervet’s worldwide leadership and focused R&D initiatives provide a solid foundation for the delivery of new technologies designed to answer a variety of unmet medical needs of our pets." Intervet, a division of Intervet International, reports it plans to have a presence at all major veterinary conventions in 2005, starting with the North American Veterinary Conference in Orlando in January. <HOME>
